Cubist Systematic Strategies’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Cubist Systematic Strategies’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,747	Closed	-$173K	–	2035
2016 Q4	$173K	Buy	+4,747	New	+$168K	0.01%	1313

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Cubist Systematic Strategies's CLCD Position: Q1 2017 in Review

Cubist Systematic Strategies sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 4,747 shares — an estimated $173K sold.

Cubist Systematic Strategies first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $173K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Cubist Systematic Strategies reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Cubist Systematic Strategies sold 4,747 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $173K.
Cubist Systematic Strategies first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
Cubist Systematic Strategies's CoLucid Pharmaceuticals, Inc. position peaked at $173K in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Cubist Systematic Strategies's 13F filing for Q1 2017, filed 15 May 2017.